Rising and Higher Healthcare Resource Utilization (HCRU) and Costs of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH) Patients with Advanced Liver Disease of Increasing Severity - Results of a US Real-World Analysis

被引：0
|
作者：
Wong, Robert J. [1 ]
Kachru, Nandita [2 ]
Meyer, Nicole [3 ]
Gordon, Stuart C. [4 ]
机构：
[1] Highland Hosp, Alameda Hlth Syst, Div Gastroenterol & Hepatol, Oakland, CA USA
[2] Gilead Sci, Foster City, CA USA
[3] Truven Hlth Analyt, Cambridge, MA USA
[4] Henry Ford Hlth Syst, Detroit, MI USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2268
引用
收藏
页码：1283A / 1284A
页数：2
相关论文
共 50 条
  • [21] The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
    Younossi, Zobair M.
    Golabi, Pegah
    Paik, James M.
    Henry, Austin
    Van Dongen, Catherine
    Henry, Linda
    HEPATOLOGY, 2023, 77 (04) : 1335 - 1347
  • [22] Variants of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) with rapidly progressive course
    Tan, V.
    Jimenez, C.
    Merriman, R.
    Ferrell, L.
    MODERN PATHOLOGY, 2008, 21 : 317A - 317A
  • [23] Higher Rates of Disease Progression among Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients with Advanced Fibrosis (AF) and Diabetes Mellitus (DM)
    Younossi, Zobair
    Kachru, Nandita
    Shreay, Sanatan
    Loomba, Rohit
    DIABETES, 2019, 68
  • [24] Increasing risk of disease progression and mortality in nonalcoholic fatty liver disease/non-alcoholic steatohepatitis patients with advanced liver disease: A german real-world analysis
    Canbay, Ali
    Kachru, Nandita
    Meise, Dominic
    Haas, Jennifer Scarlet
    Ozbay, Ahmet Burak
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E36 - E36
  • [25] Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany
    Canbay, Ali
    Kachru, Nandita
    Haas, Jennifer Scarlet
    Meise, Dominic
    Ozbay, A. Burak
    Sowa, Jan-Peter
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [26] Identification and Characterization of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients with Advanced Liver Fibrosis Identified Using Noninvasive Test (NIT) of Hepatic Fibrosis: Real-World Results of 3,421 Patients
    Younossi, Zobair M.
    Shreay, Sanatan
    Parker, Emily
    Loomba, Rohit
    HEPATOLOGY, 2018, 68 : 614A - 615A
  • [27] Increased Health-Care Resource Utilization (HRU) and Costs among Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients with Advanced Fibrosis (AF) having Diabetes Mellitus (DM)
    Gordon, Stuart
    Kachru, Nandita
    Ozbay, A. Burak
    Wong, Robert
    DIABETES, 2019, 68
  • [28] PATHOGENETIC ANALYSIS OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) WITH MULTI-CELL-LINEAGE HUMAN LIVER ORGANOIDS
    Zhang, Wenjun
    Park, Yujin
    Thadasina, Deepthi
    Thi Minh Uyen Le
    Li, Ping
    Ekser, Burcin
    HEPATOLOGY, 2023, 78 : S1121 - S1122
  • [29] DIAGNOSING NONALCOHOLIC STEATOHEPATITIS (NASH) AMONG PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD): FEQUENCY AND PREDICTORS OF NAFLD ACTIVITY SCORE MEASUREMENT
    Katz, J.
    Heinz, S.
    DiBonaventura, M.
    VALUE IN HEALTH, 2017, 20 (05) : A180 - A180
  • [30] Role of Genetic Polymorphisms in the Development of Nonalcoholic Fatty Liver Disease (NAFLD) and Steatohepatitis (NASH)
    Bril, Fernando
    Kawaguchi-Suzuki, Marina
    Frye, Reginald
    Sanchez, Paola Portillo
    Maximos, Maryann
    Lai, Song
    Hardies, Jean
    Tio, Fermin
    Cusi, Kenneth
    HEPATOLOGY, 2014, 60 : 585A - 585A
12345